Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cerus Corporation stock logo
CERS
Cerus
$1.50
-3.8%
$1.35
$1.12
$2.54
$294.39M1.561.33 million shs388,973 shs
Neogen Corporation stock logo
NEOG
Neogen
$5.33
+1.8%
$5.60
$3.87
$18.58
$1.16B1.773.51 million shs4.02 million shs
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
$3.08
+0.7%
$2.84
$2.36
$4.92
$230.38M0.45752,577 shs304,101 shs
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$17.85
+1.7%
$17.94
$13.50
$49.86
$884.54M0.58852,084 shs259,813 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cerus Corporation stock logo
CERS
Cerus
0.00%+5.63%+4.17%+20.97%-12.79%
Neogen Corporation stock logo
NEOG
Neogen
0.00%+12.58%+7.36%-31.73%-64.99%
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
0.00%+2.33%+6.21%-0.96%-23.57%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
0.00%+5.50%+7.08%+12.12%-58.59%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cerus Corporation stock logo
CERS
Cerus
3.3715 of 5 stars
3.54.00.00.03.41.70.6
Neogen Corporation stock logo
NEOG
Neogen
4.0403 of 5 stars
3.34.00.00.01.93.32.5
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
1.03 of 5 stars
1.02.00.04.20.01.70.6
STAAR Surgical Company stock logo
STAA
STAAR Surgical
4.1246 of 5 stars
3.01.00.04.13.23.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cerus Corporation stock logo
CERS
Cerus
3.00
Buy$3.50133.33% Upside
Neogen Corporation stock logo
NEOG
Neogen
2.50
Moderate Buy$7.5040.85% Upside
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
2.00
Hold$3.00-2.60% Downside
STAAR Surgical Company stock logo
STAA
STAAR Surgical
2.00
Hold$24.6337.96% Upside

Current Analyst Ratings Breakdown

Latest CERS, NEOG, STAA, and OSUR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/30/2025
Neogen Corporation stock logo
NEOG
Neogen
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$13.00 ➝ $10.00
6/18/2025
STAAR Surgical Company stock logo
STAA
STAAR Surgical
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
5/27/2025
STAAR Surgical Company stock logo
STAA
STAAR Surgical
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold$20.00
5/21/2025
STAAR Surgical Company stock logo
STAA
STAAR Surgical
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
5/19/2025
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingIn-Line ➝ In-Line$3.00 ➝ $3.00
5/8/2025
STAAR Surgical Company stock logo
STAA
STAAR Surgical
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$17.00 ➝ $20.00
4/22/2025
Neogen Corporation stock logo
NEOG
Neogen
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$6.40 ➝ $5.00
4/21/2025
STAAR Surgical Company stock logo
STAA
STAAR Surgical
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$17.00
4/14/2025
Neogen Corporation stock logo
NEOG
Neogen
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$13.00 ➝ $6.50
4/10/2025
Neogen Corporation stock logo
NEOG
Neogen
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $13.00
(Data available from 7/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cerus Corporation stock logo
CERS
Cerus
$180.27M1.59N/AN/A$0.31 per share4.84
Neogen Corporation stock logo
NEOG
Neogen
$924.22M1.25$1.02 per share5.20$14.52 per share0.37
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
$185.83M1.24$0.04 per share79.33$5.50 per share0.56
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$313.90M2.82N/AN/A$8.06 per share2.21
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cerus Corporation stock logo
CERS
Cerus
-$20.92M-$0.10N/AN/AN/A-10.23%-34.81%-9.68%7/30/2025 (Estimated)
Neogen Corporation stock logo
NEOG
Neogen
-$9.42M-$2.23N/A10.87N/A-53.56%2.69%1.82%7/29/2025 (Estimated)
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
-$19.50M-$0.42N/AN/AN/A-19.77%-5.86%-5.20%8/5/2025 (Estimated)
STAAR Surgical Company stock logo
STAA
STAAR Surgical
-$20.21M-$1.44N/AN/AN/A-25.46%-10.59%-8.32%8/6/2025 (Estimated)

Latest CERS, NEOG, STAA, and OSUR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/29/2025Q4 2025
Neogen Corporation stock logo
NEOG
Neogen
$0.09N/AN/AN/A$222.52 millionN/A
5/1/2025Q1 2025
Cerus Corporation stock logo
CERS
Cerus
-$0.05-$0.04+$0.01-$0.04$47.44 million$43.24 million
4/9/2025Q3 2025
Neogen Corporation stock logo
NEOG
Neogen
$0.12$0.10-$0.02-$0.05$225.27 million$221.00 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cerus Corporation stock logo
CERS
Cerus
N/AN/AN/AN/AN/A
Neogen Corporation stock logo
NEOG
Neogen
N/AN/AN/AN/AN/A
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
N/AN/AN/AN/AN/A
STAAR Surgical Company stock logo
STAA
STAAR Surgical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cerus Corporation stock logo
CERS
Cerus
1.15
2.32
1.63
Neogen Corporation stock logo
NEOG
Neogen
0.33
3.91
2.45
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
N/A
12.34
10.94
STAAR Surgical Company stock logo
STAA
STAAR Surgical
N/A
4.78
4.07

Institutional Ownership

CompanyInstitutional Ownership
Cerus Corporation stock logo
CERS
Cerus
78.37%
Neogen Corporation stock logo
NEOG
Neogen
96.73%
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
93.50%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
96.70%

Insider Ownership

CompanyInsider Ownership
Cerus Corporation stock logo
CERS
Cerus
5.60%
Neogen Corporation stock logo
NEOG
Neogen
1.13%
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
3.90%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
1.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cerus Corporation stock logo
CERS
Cerus
290191.16 million180.46 millionOptionable
Neogen Corporation stock logo
NEOG
Neogen
2,110217.04 million214.59 millionOptionable
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
84074.80 million71.88 millionOptionable
STAAR Surgical Company stock logo
STAA
STAAR Surgical
96049.53 million49.03 millionOptionable

Recent News About These Companies

Staar Surgical Holds Annual Shareholders Meeting

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cerus stock logo

Cerus NASDAQ:CERS

$1.50 -0.06 (-3.85%)
Closing price 07/3/2025 03:54 PM Eastern
Extended Trading
$1.53 +0.03 (+2.00%)
As of 07/3/2025 04:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California.

Neogen stock logo

Neogen NASDAQ:NEOG

$5.32 +0.10 (+1.82%)
Closing price 07/3/2025 01:46 PM Eastern
Extended Trading
$5.32 0.00 (0.00%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

OraSure Technologies stock logo

OraSure Technologies NASDAQ:OSUR

$3.08 +0.02 (+0.65%)
As of 07/3/2025 03:36 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of void urine samples; and microbiome laboratory testing and analytical services. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Additionally, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.

STAAR Surgical stock logo

STAAR Surgical NASDAQ:STAA

$17.85 +0.29 (+1.65%)
Closing price 07/3/2025 01:23 PM Eastern
Extended Trading
$17.86 +0.00 (+0.03%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.